For pharma and biopharma companies, building quality into your products from an early stage is a key factor in regulatory approval and market success. Thus, the FDA mentions “Design of Experiments” (DoE) as an essential tool for achieving both regulatory compliance and faster time to market. Eminence Business Media is planning a two-day robust training program on “Advance DoE Workshop 2024” on May 9th – 10th. 2024 focuses on Towards Implementing Pharma QbD: Recent Paradigms and Techniques of Quintessential DoE.
CONTACT PERSON NAME: Suryansh Rana
CONTACT PERSON EMAIL ID: suryansh@eminencemedia.in